Authors: Traeger-Synodinos, J Papassotiriou, I Metaxotou-Mavrommati, A Vrettou, C Stamoulakatou, A Kanavakis, E

Citation: J. Traeger-synodinos et al., Distinct phenotypic expression associated with a new hyperunstable alpha globin variant (Hb Heraklion, alpha 1cd37(C2)Pro > 0): Comparison to other alpha-thalassemic hemoglobinopathies, BL CELL M D, 26(4), 2000, pp. 276-284

Authors: Vrettou, C Kanavakis, E Traeger-Synodinos, J Metaxotou-Mavrommati, A Basiakos, I Maragoudaki, E Stamoulakatou, A Papassotiriou, I Kattamis, C

Citation: C. Vrettou et al., Molecular studies of beta-thalassemia heterozygotes with raised Hb F levels, HEMOGLOBIN, 24(3), 2000, pp. 203-220

Authors: Kanavakis, E Papassotiriou, I Karagiorga, M Vrettou, C Metaxotou-Mavrommati, A Stamoulakatou, A Kattamis, C Traeger-Synodinos, J

Citation: E. Kanavakis et al., Phenotypic and molecular diversity of haemoglobin H disease: a Greek experience, BR J HAEM, 111(3), 2000, pp. 915-923

Authors: Traeger-Synodinos, J Metaxotou-Mavrommati, A Karagiorga, M Vrettou, C Papassotiriou, I Stamoulakatou, A Kanavakis, E

Citation: J. Traeger-synodinos et al., Interaction of an alpha(+)-thalassemia deletion with either a highly unstable alpha-globin variant (alpha 2, codon 59, G(G)under-barC -> G(A)under-barC) or a nondeletional alpha-thalassemia mutation (AATAA(A)under-bar -> AATAA(G)under-bar): Comparison of phenotypes illustrating "dominant" alpha-thalassemia, HEMOGLOBIN, 23(4), 1999, pp. 325-337

Authors: Maragoudaki, E Kanavakis, E Traeger-Synodinos, J Vrettou, C Tzetis, M Metaxotou-Mavrommati, A Kattamis, C

Citation: E. Maragoudaki et al., Molecular, haematological and clinical studies of the-101 C -> T substitution of the beta-globin gene promoter in 25 beta-thalassaemia intermedia patients and 45 heterozygotes, BR J HAEM, 107(4), 1999, pp. 699-706